Dna Biopharm
FDA import alert and refusal historyCapetown, South AfricaFEI 3015251424
Recorded by FDA as DNA BIOPHARM
As of October 26, 2026, Dna Biopharm is not on any FDA import alert in SupplierRadar's records; FDA refused 2 of its shipment lines on April 24, 2019, most often for not identified as a dietary supplement (DIETARYLBL).
Data from FDA public records, last checked . Request a correction
Current status
- Import alerts
- Not listed
- Last import refusal
- Vitamin, mineral, proteins and unconventional dietary specialities for humans and animals, n.e.c. · DIETARYLBL
- Last warning letter
- None found
- Last inspection
- None on record
Every FDA record for Dna Biopharm
2 records, newest first. Each line links to the FDA page it came from.
2019
- Import refusalSource
Refused, 2 lines in one entry: Vitamin, mineral, proteins and unconventional dietary specialities for humans and animals, n.e.c.DIETARYLBLNCONTACTHEALTH CUNAPPROVEDEntry SCS-4248479-1Show 2 linesHide lines
- Refused, Vitamin, mineral, proteins and unconventional dietary specialities for humans and animals, n.e.c.DIETARYLBLNCONTACTHEALTH CUNAPPROVEDEntry SCS-4248479-1Source
- Refused, Vitamin, mineral, proteins and unconventional dietary specialities for humans and animals, n.e.c.DIETARYLBLNCONTACTHEALTH CUNAPPROVEDEntry SCS-4248479-1Source
Refusal charges, in plain English
- DIETARYLBL2 refused lines
Not identified as a dietary supplement
The label appeared not to identify the product with the term "dietary supplement" (which may be modified with the name of an ingredient).
- HEALTH C2 refused lines
Unauthorized nutrient content or health claim
The label or labeling appeared to carry a nutrient content claim or health claim that is not authorized.
- NCONTACT2 refused lines
No U.S. adverse event contact on supplement label
The dietary supplement label appeared not to show a U.S. address or phone number through which a serious adverse event can be reported.
- UNAPPROVED2 refused lines
Unapproved new drug
The product appeared to be a new drug within the meaning of section 201(p) of the FD&C Act without an approved New Drug Application. FDA can apply this charge to a food or supplement whose labeling presents it for drug uses.
Questions about Dna Biopharm
- Is Dna Biopharm on an FDA import alert?
- No listing for Dna Biopharm appears in the FDA import alerts SupplierRadar checked on October 26, 2026. Country-wide alerts may still apply to its products; see the South Africa page.
- Has FDA refused shipments from Dna Biopharm?
- Yes. FDA refused 2 shipment lines from Dna Biopharm on April 24, 2019. The most recent, on April 24, 2019, was vitamin, mineral, proteins and unconventional dietary specialities for humans and animals, n.e.c., charged as DIETARYLBL (not identified as a dietary supplement).
- Why did FDA refuse Dna Biopharm's shipments?
- The most frequent charges are DIETARYLBL (not identified as a dietary supplement, 2 lines) and HEALTH C (unauthorized nutrient content or health claim, 2 lines).
- What is Dna Biopharm's FEI number?
- Dna Biopharm's FDA Establishment Identifier (FEI) is 3015251424.
Buying from Dna Biopharm?
Watch it and get the FDA record the day it changes. Free for one supplier.
SupplierRadar is not affiliated with the U.S. Food and Drug Administration. Data comes from public FDA records and may contain errors. This is not legal advice; importers remain responsible for their supplier evaluations.